​

Funding Round

Series A - AIRNA

Series A - AIRNA

Investment Firm

Overview

AIRNA is a biotech company that is pioneering RNA editing therapies to improve the health of individuals.

Announced Date

Sep 19, 2023

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

ARCH Venture Partners

ARCH Venture Partners

ARCH Venture Partners is a convertible_note and debt and early_stage_venture and late_stage_venture and post_ipo and seed and venture firm.

Participant Investors

3

Investor Name
Participant InvestorCodon Capital
Participant Investor+ND Capital
Participant InvestorARCH Venture Partners

Round Details and Background

AIRNA raised $30000000 on 2023-09-19 in Series A

AIRNA is a biotech company that is pioneering RNA editing therapies to improve the health of individuals.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Sep 19, 2023
Series A - AIRNA
5-30.0M
Jul 31, 2024
Series A - AIRNA
5-60.0M

Recent Activity

There is no recent news or activity for this profile.